The Next Wave: “First in Class” or “Best in Class”
TSE-424 for HRT and Osteoporosis
Phase III to Begin 2Q01
GAR-936 for Antibiotic Resistant Infections
Phase III Planned 2Q01
CCI-779 for Oncology
Phase II Began 2Q00
rPSGL-Ig for Acute Myocardial Infarction
Phase II Began 3Q00
PTP-112 for Type 2 Diabetes
Phase I Began 2Q00
Previous slide
Next slide
Back to first slide
View graphic version